Posted in | News | Mining Business | Alumina

Hudson Begins White Mountain Anorthosite Project Prefeasibility Study

HUDSON RESOURCES INC. (the "Company") is pleased to announce that the prefeasibility study for the company's White Mountain Anorthosite project has commenced. The study is being carried out by Hains Engineering of Toronto who have extensive experience with anorthosite projects in North America and Europe.

The study is expected to be completed in Q3 of 2013. The study is focused on the production of an anorthosite feed material that will be utilized by the E-Glass fiberglass industry. The study will be based on an open pit mine adjacent to tidewater in Greenland, together with a processing and distribution facility in Western Europe.

James Tuer, Hudson's President, stated, "We are very pleased with the rapid progress on our White Mountain anorthosite project. In just over a year we have outlined a significant 43-101 resource model, extracted a bulk sample, determined a flow sheet and initiated discussions with five potential end users in the E-Glass industry. The commencement of the prefeasibility is an important step in determining the economics of the project. This study will be initially based on European end users, but we are also actively looking at markets in North America and Asia with very positive feedback to date. We will continue to work rapidly to advance the project under Greenland's streamlined permitting process and expect to submit an application for an exploitation license in early 2014."

Hudson announced a 43-101 compliant resource model on January 30th (see release NR2013-03). This resource estimate outlined an indicated resource of 27.4M tonnes together with an inferred resource of 32.7 M tonnes. The resource parameters and 2.50% sodium (Na2O) cut-off are based on the feedstock requirements needed for the E-Glass (fiberglass) industry. Hudson believes the resource is unique due to its high calcium, low sodium content. The resource remains open in all directions.

Hudson has determined that the White Mountain anorthosite has three potential high-value industrial applications:

  • As a new source of feedstock to the high end fiberglass (E-glass) industry;
  • As a new source of alumina to supply aluminum smelters; and
  • As a new source of filler material. Fillers are a significant component in the plastics and paints industries.

Hudson commenced exploration on the White Mountain Project in January 2012 and has completed over 4,300 meters of drilling in 45 drill holes at White Mountain. Processing of the 120 tonne sample is nearing completion at the Saskatchewan Research Council's pilot plant in Saskatoon. The resulting feldspar concentrate will be shipped to Europe later this month for trial tests. Based on bench scale testing, the material requires minimal processing: crushing, grinding, magnetic separation and milling. The Company has also initiated baseline environmental studies with the objective of submitting an application for a mining license in early 2014.

The White Mountain Project is owned 100% by Hudson. The Project is located on tidewater approximately 40 km from the Company's 100% owned rare earth element (REE) project. The Company remains well-financed with over $6 million in working capital.

Dr. Michael Druecker is a qualified person as defined by National Instrument 43-101 and reviewed the preparation of the scientific and technical information in this press release. Ronald G. Simpson, B.Sc., P,Geo., President of Geosim Services Inc., an independent Qualified Person as defined by NI 43-101, was responsible for the resource estimate on White Mountain.

ON BEHALF OF THE BOARD OF DIRECTORS

James Tuer, President

Source: http://www.hudsonresources.ca/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.